Skip to main content
People
Services
Practices
View Featured Practices
Advertising and Marketing
Antitrust
Bankruptcy and Restructuring
Corporate and Tax
Employment and Employee Benefits
Environmental
Government Contracts
Government Relations and Public Policy
Intellectual Property
International Trade
Litigation
Privacy and Information Security
Real Estate
Search Services
Industries
View Featured Industries
Animals
Communications
Energy
Fashion and Retail
Financial Institutions
Food and Drug
Manufacturing
Media and Entertainment
Public Sector and Government Entities
Railroads
Technology
Trade Associations
Waterways
Search Services
Trending
View All Trending
Advertising Technology
Economic Consulting and Data Analytics (GES)
Environmental, Social and Governance (ESG)
Forced Labor Trade Enforcement
India-U.S. Cross-Border Transactions and Disputes
PFAS and Emerging Contaminants
Client Experience
Overview
Client Service Standards
Strategic Pricing
Innovation
Security and Risk
Viewpoints
Viewpoints
Overview
Client Advisories
Articles
Blogs
Ad Law Access
CommLaw Monitor
Kelley Green Law
Labor Days
Trade and Manufacturing Monitor
Newsletters
Ad Law News and Views
TCPA Tracker
USF Tracker
News from the DC Business Group
Podcasts
Ad Law Access Podcast
Full Spectrum
Legal Download
People
Services
Practices
Industries
Trending
Client Experience
Overview
Client Service Standards
Strategic Pricing
Innovation
Security and Risk
Viewpoints
Overview
Blogs
Newsletters
Podcasts
Client Advisories
Articles
Locations
Careers
News
Events
Responsible Business
Diversity and Inclusion
Pro Bono
About Us
Contact us
Subscribe
Viewpoints
/
Client Advisories
/
New Internal Revenue Service Ruling Authorizes Use of Pre-Tax Dollars for Over-The-Counter Medicines
New Internal Revenue Service Ruling Authorizes Use of Pre-Tax Dollars for Over-The-Counter Medicines
Pamela D. Kaplan
October 13, 2003
Kelley Drye Client Advisory
Back to Top
!
Information:
✓
Success:
×
Error:
Close notification